We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Olaparib Tablets as a Treatment for Ovarian Cancer Subjects With Different HRD Tumor Status

This study is currently recruiting participants.
Verified October 2017 by AstraZeneca
Sponsor:
ClinicalTrials.gov Identifier:
NCT02983799
First Posted: December 6, 2016
Last Update Posted: October 24, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
AstraZeneca
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 23, 2019
  Estimated Primary Completion Date: October 23, 2019 (Final data collection date for primary outcome measure)